Abstract Form - Diabetes Pro - American Diabetes Association printable pdf download

ABSTRACT FORM

Research Symposium

Epigenetics and Epigenomics: Implications for Diabetes and Obesity

November 17-19, 2017

Boston, Massachusetts, USA

Submission Deadline –AUGUST 18, 2017

CONTACT INFORMATION OF PRESENTING AUTHOR (please type)

First Name_____________________________________ Last Name__________________________________________________________

Employer ________________________________________________________________________________________________________

Address __________________________________________________________________________________________________________

_________________________________________________________________________________________________________________

City__________________________State_________________Country____________________________________Zip__________________

Telephone: ______________________ Fax: _________________________ Email: _____________________________________________

GUIDELINES

1. Email your abstract to Shirley Ash at no later than August 18, 2017.

2. Submit this form and completed disclosure form(s) to .

3. If you do not get a receipt confirmation from me within three (3) days please call me at 703-549-1500, x2214.

4. Acceptance and presentation of an abstract at this meeting does not preclude its presentation at ADA’s 78th

Scientific Sessions.

5. The Disclosure Form must be completed for each submission and by all authors. Please designate the

presenting author.

6. ABSTRACT (including title, author’s name, figures, tables, graphs, etc.) are limited to 2,325 characters (as a

guide figures usually use 320 characters and tables/graphs depend on the amount of text). Abstract must be

submitted as a Word Document.

7. The heading of submitted abstracts should be in the following format: a. Title(s), all letters capitalized;

b. Author(s) names(s) preceded by initials or first name(s), with only first letters of first and last name(s)

capitalized; c. City and State of origin of work, do not list street address and zip code. Refer to the example

below:

THE EVOLUTION OF EPIGENETICS: FROM PROKARYOTES TO HUMANS AND ITS BIOLOGICAL

CONSEQUENCES. S Sarkar, A Willbanks, M Greenshields, C Tyminski, S Heerboth, K Lapinsky, K Haskins,

M Leary, Boston, MA

8. Only abstracts received by August 18, 2017 will be considered for presentation at the symposium. Accepted

abstracts will appear in the program syllabus. The primary abstract authors will be notified regarding acceptance

of abstracts by September 15, 2017.

9. Abstract submissions should focus on the core content of the program: understanding the relationships between

genetics, epigenetics and epigenomics, including non-coding RNAs and environment in diabetes, and further

investigating the role of epigenetic factors in regulating metabolism and increasing the risk for diabetes and its

complications.

10. Questions should be directed to Shirley Ash at 703-549-1500, x2214 or .

Abstract Form - Diabetes Pro - American Diabetes Association